dextroamphetamine has been researched along with Actinic Reticuloid Syndrome in 1 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weiss, G | 1 |
| Werry, J | 1 |
| Minde, K | 1 |
| Douglas, V | 1 |
| Sykes, D | 1 |
1 trial available for dextroamphetamine and Actinic Reticuloid Syndrome
| Article | Year |
|---|---|
Studies on the hyperactive child. V. The effects of dextroamphetamine and chlorpromazine on behaviour and intellectual functioning.
Topics: Aggression; Child; Child Behavior Disorders; Chlorpromazine; Clinical Trials as Topic; Dextroampheta | 1968 |